CoChat

Metformin vs Insulin in the Management of Gestational Diabetes: A Meta-Analysis

Open access
Gui, Juan, Liu, Qing, Feng, Ling · 2013 · PLoS ONE

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Nowadays, there have been increasing studies comparing metformin with insulin. But the use of metformin in pregnant women is still controversial, therefore, we aim to examine the efficiency and safety of metformin by conducting a meta-analysis of randomized controlled trials (RCTs) comparing the effects of metformin with insulin on glycemic control, maternal and neonatal outcomes in gestational diabetes mellitus (GDM). METHODS: We used the key words "gestational diabetes" in combination with "metformin" and searched the databases including Pubmed, the Cochrane Library, Web of knowledge, and Clinical Trial Registries. A random-effects model was used to compute the summary risk estimates. RESULTS: Meta-analysis of 5 RCTs involving 1270 participants detected that average weight gains after enrollment were much lower in the metformin group (n = 1006, P = 0.003, SMD = -0.47, 95%CI [-0.77 to -0.16]); average gestational ages at delivery were significantly lower in the metformin group (n = 1270, P = 0.02, SMD = -0.14, 95%CI [-0.25 to -0.03]); incidence of preterm birth was significantly more in metformin group (n = 1110, P = 0.01, OR = 1.74, 95%CI [1.13 to 2.68]); the incidence of pregnancy induced hypertension was significantly less in the metformin group (n = 1110, P = 0.02, OR = 0.52, 95%CI [0.30 to 0.90]). The fasting blood sugar levels of OGTT were significantly lower in the metformin only group than in the supplemental insulin group (n = 478, P = 0.0006, SMD = -0.83, 95%CI [-1.31 to -0.36]). CONCLUSIONS: Metformin is comparable with insulin in glycemic control and neonatal outcomes. It might be more suitable for women with mild GDM. This meta-analysis also provides some significant benefits and risks of the use of metformin in GDM and help to inform further development of management guidelines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0064585

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow of study identification, inclusion, and exclusion.
Figure 1 Flow of study identification, inclusion, and exclusion.CC BY · PubMed Central
Figure 2 Forest plot of main maternal risks comparing metformin with insulin. a: weight gain after enrollment; b: gestational age at delivery; c: incidence of preterm birth; d: incidence of PIH; e: incidence of preeclampsia. SMD: standard mean differences; CI: confidence intervals; OR: odds ratio; PIH: pregnancy induced hypertension.
Figure 2 Forest plot of main maternal risks comparing metformin with insulin. a: weight gain after enrollment; b: gestational age at delivery; c: incidence of preterm birth; d: incidence of PIH; e: incidence of preeclampsia. SMD: standard mean differences; CI: confidence intervals; OR: odds ratio; PIH: pregnancy induced hypertension.CC BY · PubMed Central
Figure 3 Forest plot of main neonatal risks comparing metformin with insulin. a: birth weight; b: incidence of LGA infants; c: incidence of SGA infants; d: incidence of hypoglycemia. SMD: standard mean differences; CI: confidence intervals; OR: odds ratio; LGA: large for gestational age; SGA: small for gestational age.
Figure 3 Forest plot of main neonatal risks comparing metformin with insulin. a: birth weight; b: incidence of LGA infants; c: incidence of SGA infants; d: incidence of hypoglycemia. SMD: standard mean differences; CI: confidence intervals; OR: odds ratio; LGA: large for gestational age; SGA: small for gestational age.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

Items 201–220 of 220

Metadata

Authors
Gui, J., Liu, Q., & Feng, L.
Affiliations
Tongji Hospital (CN)
Corresponding author
Feng, Ling
Venue
PLoS ONE
Published
2013-05-27
Volume
8
Issue
5
Pages
e64585
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2109810300
Cited by
222
References
37
Citations by year
2026: 4 · 2025: 8 · 2024: 13 · 2023: 16 · 2022: 13 · 2021: 22 · 2020: 15 · 2019: 19 · 2018: 31 · 2017: 13 · 2016: 12 · 2015: 34 · 2014: 19 · 2013: 3
FWCI
3.88
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
metformin, insulin, gestational diabetes mellitus, glycemic control, maternal outcomes, neonatal outcomes, preterm birth, gestational hypertension, gestational weight gain, fasting blood glucose, oral glucose tolerance test
MeSH terms
Birth Weight, Female, Humans, Hypoglycemic Agents, Infant, Newborn, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Diabetes, Gestational, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.